
{
    "FullStudiesResponse":{
      "APIVrs":"1.01.05",
      "DataVrs":"2023:08:16 23:57:56.293",
      "Expression":"NCT04516746",
      "NStudiesAvail":462815,
      "NStudiesFound":1,
      "MinRank":1,
      "MaxRank":1,
      "NStudiesReturned":1,
      "FullStudies":[
        {
          "Rank":1,
          "Study":{
            "ProtocolSection":{
              "IdentificationModule":{
                "NCTId":"NCT04516746",
                "OrgStudyIdInfo":{
                  "OrgStudyId":"D8110C00001"
                },
                "Organization":{
                  "OrgFullName":"AstraZeneca",
                  "OrgClass":"INDUSTRY"
                },
                "BriefTitle":"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",
                "OfficialTitle":"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19"
              },
              "StatusModule":{
                "StatusVerifiedDate":"March 2023",
                "OverallStatus":"Completed",
                "ExpandedAccessInfo":{
                  "HasExpandedAccess":"No"
                },
                "StartDateStruct":{
                  "StartDate":"August 28, 2020",
                  "StartDateType":"Actual"
                },
                "PrimaryCompletionDateStruct":{
                  "PrimaryCompletionDate":"March 5, 2021",
                  "PrimaryCompletionDateType":"Actual"
                },
                "CompletionDateStruct":{
                  "CompletionDate":"February 10, 2023",
                  "CompletionDateType":"Actual"
                },
                "StudyFirstSubmitDate":"August 17, 2020",
                "StudyFirstSubmitQCDate":"August 17, 2020",
                "StudyFirstPostDateStruct":{
                  "StudyFirstPostDate":"August 18, 2020",
                  "StudyFirstPostDateType":"Actual"
                },
                "ResultsFirstSubmitDate":"March 3, 2022",
                "ResultsFirstSubmitQCDate":"March 31, 2022",
                "ResultsFirstPostDateStruct":{
                  "ResultsFirstPostDate":"April 1, 2022",
                  "ResultsFirstPostDateType":"Actual"
                },
                "ResultsFirstPostedQCCommentsDateStruct":{
                  "ResultsFirstPostedQCCommentsDate":"March 21, 2022",
                  "ResultsFirstPostedQCCommentsDateType":"Actual"
                },
                "LastUpdateSubmitDate":"March 10, 2023",
                "LastUpdatePostDateStruct":{
                  "LastUpdatePostDate":"April 7, 2023",
                  "LastUpdatePostDateType":"Actual"
                }
              },
              "SponsorCollaboratorsModule":{
                "ResponsibleParty":{
                  "ResponsiblePartyType":"Sponsor"
                },
                "LeadSponsor":{
                  "LeadSponsorName":"AstraZeneca",
                  "LeadSponsorClass":"INDUSTRY"
                },
                "CollaboratorList":{
                  "Collaborator":[
                    {
                      "CollaboratorName":"Iqvia Pty Ltd",
                      "CollaboratorClass":"INDUSTRY"
                    }
                  ]
                }
              },
              "OversightModule":{
                "OversightHasDMC":"Yes",
                "IsFDARegulatedDrug":"Yes",
                "IsFDARegulatedDevice":"No"
              },
              "DescriptionModule":{
                "BriefSummary":"The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.",
                "DetailedDescription":"The COVID-19 pandemic has caused major disruption to healthcare systems with significant socioeconomic impacts. Currently, there are no specific treatments available against COVID-19 and accelerated vaccine development is urgently needed. A safe and effective vaccine for COVID-19 prevention would have significant public health impact."
              },
              "ConditionsModule":{
                "ConditionList":{
                  "Condition":[
                    "COVID-19",
                    "SARS-CoV-2"
                  ]
                },
                "KeywordList":{
                  "Keyword":[
                    "COVID-19 Vaccine"
                  ]
                }
              },
              "DesignModule":{
                "StudyType":"Interventional",
                "PhaseList":{
                  "Phase":[
                    "Phase 3"
                  ]
                },
                "DesignInfo":{
                  "DesignAllocation":"Randomized",
                  "DesignInterventionModel":"Parallel Assignment",
                  "DesignInterventionModelDescription":"Participants are assigned to one of two or more groups in parallel for the duration of the study.",
                  "DesignPrimaryPurpose":"Treatment",
                  "DesignMaskingInfo":{
                    "DesignMasking":"Quadruple",
                    "DesignMaskingDescription":"Double Blind: two or more parties are unaware of the intervention assignment.",
                    "DesignWhoMaskedList":{
                      "DesignWhoMasked":[
                        "Participant",
                        "Care Provider",
                        "Investigator",
                        "Outcomes Assessor"
                      ]
                    }
                  }
                },
                "EnrollmentInfo":{
                  "EnrollmentCount":"32459",
                  "EnrollmentType":"Actual"
                }
              },
              "ArmsInterventionsModule":{
                "ArmGroupList":{
                  "ArmGroup":[
                    {
                      "ArmGroupLabel":"AZD1222",
                      "ArmGroupType":"Experimental",
                      "ArmGroupDescription":"Approximately 20,000 participants randomized to the AZD1222 arm",
                      "ArmGroupInterventionList":{
                        "ArmGroupInterventionName":[
                          "Biological: AZD1222"
                        ]
                      }
                    },{
                      "ArmGroupLabel":"Placebo",
                      "ArmGroupType":"Placebo Comparator",
                      "ArmGroupDescription":"Approximately 10,000 participants randomized to the saline placebo arm",
                      "ArmGroupInterventionList":{
                        "ArmGroupInterventionName":[
                          "Biological: Placebo"
                        ]
                      }
                    }
                  ]
                },
                "InterventionList":{
                  "Intervention":[
                    {
                      "InterventionType":"Biological",
                      "InterventionName":"AZD1222",
                      "InterventionDescription":"AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2-5 surface glycoprotein.",
                      "InterventionArmGroupLabelList":{
                        "InterventionArmGroupLabel":[
                          "AZD1222"
                        ]
                      }
                    },{
                      "InterventionType":"Biological",
                      "InterventionName":"Placebo",
                      "InterventionDescription":"Commercially available 0.9% (n/V) saline for injection.",
                      "InterventionArmGroupLabelList":{
                        "InterventionArmGroupLabel":[
                          "Placebo"
                        ]
                      }
                    }
                  ]
                }
              },
              "OutcomesModule":{
                "PrimaryOutcomeList":{
                  "PrimaryOutcome":[
                    {
                      "PrimaryOutcomeMeasure":"Number of Participants Achieving Binary Response",
                      "PrimaryOutcomeDescription":"A binary response, whereby a participant with negative serostatus at baseline is defined as a COVID-19 case if their first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurs ≥ 15 days post second dose of study intervention. Otherwise, a participant is not defined as a COVID-19 case. The primary efficacy analysis was performed once approximately 150 events meeting the primary efficacy outcome measure definition had occurred across the AZD1222 and placebo groups.",
                      "PrimaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "PrimaryOutcomeMeasure":"Number of Participants With Adverse Events (AEs) Occurring Post Each Dose of Study Intervention",
                      "PrimaryOutcomeDescription":"An AE is the development of any untoward medical occurrence in a clinical study participant administered medicinal product and which does not necessarily have a causal relationship with this medicinal product. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.",
                      "PrimaryOutcomeTimeFrame":"From Day 1 up to 28 days post second dose of study intervention, approximately 57 days"
                    },{
                      "PrimaryOutcomeMeasure":"Number of Participants With Serious Adverse Events (SAE), Medically Attended Adverse Events (MAAE), and Adverse Event of Special Interest (AESI) Occurring Throughout the Study",
                      "PrimaryOutcomeDescription":"An SAE is an AE occurring during any study phase that fulfils one or more of the following criteria: death; immediately life-threatening; in-participant hospitalization or prolongation of existing hospitalization; persistent or significant disability or incapacity; congenital abnormality or birth defect; an important medical event. AESIs were events of scientific and medical interest specific to the further understanding of the study intervention safety profile and required close monitoring and rapid communication by the investigators to the sponsor. MAAEs are defined as AEs leading to medically-attended visits that were not routine visits for physical examination or vaccination, such as an emergency room visit, or an otherwise unscheduled visit to or from medical personnel (medical doctor) for any reason.",
                      "PrimaryOutcomeTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks"
                    },{
                      "PrimaryOutcomeMeasure":"Number of Participants With Local and Systemic Solicited AEs in the Substudy Only",
                      "PrimaryOutcomeDescription":"Solicited AEs are local or systemic predefined events for assessment of reactogenicity. Solicited AEs were collected in a e-Diary only for participants in the substudy.",
                      "PrimaryOutcomeTimeFrame":"From Day 1 up to 7 days post each dose of study intervention, approximately 14 days"
                    }
                  ]
                },
                "SecondaryOutcomeList":{
                  "SecondaryOutcome":[
                    {
                      "SecondaryOutcomeMeasure":"Number of Participants With First Post-intervention Response for SARS-CoV-2 Nucleocapsid Antibodies Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of the first post-intervention response (negative at baseline to positive post intervention with study intervention) for SARS-CoV-2 nucleocapsid antibodies occurring ≥ 15 days post second dose of study intervention (key secondary endpoint).",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With First COVID-19 Symptomatic Illness Using Centers for Disease Control and Prevention (CDC) Criteria Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention using CDC criteria. Participant must present with at least one of the following symptoms per CDC criteria: fever, shortness of breath, difficulty breathing, chills, cough, fatigue, muscle aches, body aches, headache, new loss of taste, new loss of smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With First COVID-19 Symptomatic Illness Using University of Oxford-Defined Symptom Criteria Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention using University of Oxford-defined symptom criteria: new onset of fever (> 100 °Fahrenheit [> 37.8 °Celsius]), cough, shortness of breath, or anosmia/ageusia.",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With First Symptomatic COVID-19 Regardless of Evidence of Prior SARS-CoV-2 Infection Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention regardless of evidence of prior SARS-CoV-2 infection (key secondary endpoint).",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With COVID-19 Severe or Critical Symptomatic Illness Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of SARS-CoV-2 RT-PCR-positive severe or critical symptomatic illness occurring ≥ 15 days post second dose of study intervention. The severity of COVID-19 was evaluated in participants with symptoms of COVID-19. Following are the findings regarding severe of critical symptomatic COVID-19: clinical signs at rest indicative of severe systemic illness; respiratory failure; evidence of shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; and death (key secondary endpoint).",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With COVID-19 Severe or Critical Symptomatic Illness Occurring Post First Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of SARS-CoV-2 RT-PCR-positive severe or critical symptomatic illness occurring post first dose of study intervention. The severity of COVID-19 was evaluated in participants with symptoms of COVID-19. Following are the findings regarding severe of critical symptomatic COVID-19: clinical signs at rest indicative of severe systemic illness; respiratory failure; evidence of shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; and death.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With COVID-19-Related Emergency Department Visits Occurring Post Second Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of COVID-19-related emergency department visits occurring ≥ 15 days post second dose of study intervention (key secondary endpoint).",
                      "SecondaryOutcomeTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks"
                    },{
                      "SecondaryOutcomeMeasure":"Geometric Mean Titers (GMTs) for SARS-CoV-2 Spike (S) and Receptor Binding Domain (RBD) Antibodies as Measured by Meso Scale Discovery (MSD) Serology Assay",
                      "SecondaryOutcomeDescription":"The GMT was calculated as the antilogarithm of Σ(log base 2 transformed titer/n), i.e. as the anti-logarithm transformation of the mean of the log-transformed titer, where 'n' is the number of participants with titer information.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"Geometric Mean Fold Rise (GMFR) for SARS-CoV-2 S and RBD Antibodies as Measured by MSD Serology Assay",
                      "SecondaryOutcomeDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. GMFR was calculated as anti-logarithm of Σ (log base 2 transformed (post-vaccination titer/ pre-vaccination titer)/n). Where 'n' is the number of participants with titer information.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"Percentage of Participants With Seroresponse to the S and RBD Antigens of AZD1222 as Measured by MSD Serology Assay",
                      "SecondaryOutcomeDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. The percentage of participants with a post-intervention seroresponse (≥ 4-fold rise in titers from baseline value to 28 days post each dose) to the S and RBD antigens of AZD1222 as measured by MSD serology assay is reported.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"GMTs for SARS-CoV-2 Neutralizing Antibodies as Measured by Pseudo-neutralization Assay",
                      "SecondaryOutcomeDescription":"The GMT was calculated as the antilogarithm of Σ(log base 2 transformed titer/n), i.e. as the anti-logarithm transformation of the mean of the log-transformed titer, where 'n' is the number of participants with titer information.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"GMFR for SARS-CoV-2 Neutralizing Antibodies as Measured by Pseudo-neutralization Assay",
                      "SecondaryOutcomeDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. GMFR was calculated as anti-logarithm of Σ (log base 2 transformed (post-vaccination titer/ pre-vaccination titer)/n). Where 'n' is the number of participants with titer information.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"Percentage of Participants With Seroresponse to SARS-CoV-2 Neutralizing Antibodies of AZD1222 as Measured by Pseudo-neutralization Assay",
                      "SecondaryOutcomeDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. The percentage of participants with a post-intervention seroresponse (≥ 4-fold rise in titers from baseline value to 28 days post each dose) to SARS-CoV-2 neutralizing antibodies of AZD1222 as measured by pseudo-neutralization assay is reported.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57"
                    },{
                      "SecondaryOutcomeMeasure":"Number of Participants With COVID-19 Symptomatic Illness Occurring Post First Dose of Study Intervention",
                      "SecondaryOutcomeDescription":"The incidence of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring post first dose of study intervention.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks"
                    }
                  ]
                }
              },
              "EligibilityModule":{
                "EligibilityCriteria":"Inclusion Criteria:\n\nIncreased risk of SARS-CoV-2 infection\nMedically stable\n\nExclusion Criteria:\n\nconfirmed or suspected immunosuppressive or immunodeficient state\nsignificant disease, disorder, or finding\nPrior or concomitant vaccine therapy for COVID-19",
                "HealthyVolunteers":"Accepts Healthy Volunteers",
                "Gender":"All",
                "MinimumAge":"18 Years",
                "MaximumAge":"130 Years",
                "StdAgeList":{
                  "StdAge":[
                    "Adult",
                    "Older Adult"
                  ]
                }
              },
              "ContactsLocationsModule":{
                "OverallOfficialList":{
                  "OverallOfficial":[
                    {
                      "OverallOfficialName":"Ann Falsey, MD",
                      "OverallOfficialAffiliation":"University of Rochester",
                      "OverallOfficialRole":"Principal Investigator"
                    },{
                      "OverallOfficialName":"Magda Sobieszczyk, MD",
                      "OverallOfficialAffiliation":"Columbia University",
                      "OverallOfficialRole":"Principal Investigator"
                    }
                  ]
                },
                "LocationList":{
                  "Location":[
                    {
                      "LocationFacility":"Research Site",
                      "LocationCity":"Phoenix",
                      "LocationState":"Arizona",
                      "LocationZip":"85018",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Scottsdale",
                      "LocationState":"Arizona",
                      "LocationZip":"85258",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Little Rock",
                      "LocationState":"Arkansas",
                      "LocationZip":"72212",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Berkeley",
                      "LocationState":"California",
                      "LocationZip":"94705",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"El Centro",
                      "LocationState":"California",
                      "LocationZip":"92243",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Los Angeles",
                      "LocationState":"California",
                      "LocationZip":"90033",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Los Angeles",
                      "LocationState":"California",
                      "LocationZip":"90095",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"San Diego",
                      "LocationState":"California",
                      "LocationZip":"92103",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"San Diego",
                      "LocationState":"California",
                      "LocationZip":"92134",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"San Francisco",
                      "LocationState":"California",
                      "LocationZip":"94102",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"San Francisco",
                      "LocationState":"California",
                      "LocationZip":"94158",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Torrance",
                      "LocationState":"California",
                      "LocationZip":"90502",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Denver",
                      "LocationState":"Colorado",
                      "LocationZip":"80204",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Danbury",
                      "LocationState":"Connecticut",
                      "LocationZip":"06810",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Coral Gables",
                      "LocationState":"Florida",
                      "LocationZip":"33134",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Lake Worth",
                      "LocationState":"Florida",
                      "LocationZip":"33462",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Miami Lakes",
                      "LocationState":"Florida",
                      "LocationZip":"33016",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Orlando",
                      "LocationState":"Florida",
                      "LocationZip":"32803",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Honolulu",
                      "LocationState":"Hawaii",
                      "LocationZip":"96814",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Meridian",
                      "LocationState":"Idaho",
                      "LocationZip":"83642",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Chicago",
                      "LocationState":"Illinois",
                      "LocationZip":"60612",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Indianapolis",
                      "LocationState":"Indiana",
                      "LocationZip":"46202",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Ankeny",
                      "LocationState":"Iowa",
                      "LocationZip":"50023",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Fairway",
                      "LocationState":"Kansas",
                      "LocationZip":"66205",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Kansas City",
                      "LocationState":"Kansas",
                      "LocationZip":"66160",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Wichita",
                      "LocationState":"Kansas",
                      "LocationZip":"67207",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Wichita",
                      "LocationState":"Kansas",
                      "LocationZip":"67214",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Lexington",
                      "LocationState":"Kentucky",
                      "LocationZip":"40509",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Lake Charles",
                      "LocationState":"Louisiana",
                      "LocationZip":"70601",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Monroe",
                      "LocationState":"Louisiana",
                      "LocationZip":"71201",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Baltimore",
                      "LocationState":"Maryland",
                      "LocationZip":"21201",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Baltimore",
                      "LocationState":"Maryland",
                      "LocationZip":"21205",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Bethesda",
                      "LocationState":"Maryland",
                      "LocationZip":"20889",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Boston",
                      "LocationState":"Massachusetts",
                      "LocationZip":"02111",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Boston",
                      "LocationState":"Massachusetts",
                      "LocationZip":"02215",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Ann Arbor",
                      "LocationState":"Michigan",
                      "LocationZip":"48109",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Royal Oak",
                      "LocationState":"Michigan",
                      "LocationZip":"48073",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Minneapolis",
                      "LocationState":"Minnesota",
                      "LocationZip":"55425",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Gulfport",
                      "LocationState":"Mississippi",
                      "LocationZip":"39503",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Butte",
                      "LocationState":"Montana",
                      "LocationZip":"59701",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Portsmouth",
                      "LocationState":"New Hampshire",
                      "LocationZip":"03801",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Berlin",
                      "LocationState":"New Jersey",
                      "LocationZip":"08009",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Albuquerque",
                      "LocationState":"New Mexico",
                      "LocationZip":"87102",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Bronx",
                      "LocationState":"New York",
                      "LocationZip":"10467",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Brooklyn",
                      "LocationState":"New York",
                      "LocationZip":"11220",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Mineola",
                      "LocationState":"New York",
                      "LocationZip":"11501",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"New York",
                      "LocationState":"New York",
                      "LocationZip":"10010",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"New York",
                      "LocationState":"New York",
                      "LocationZip":"10016",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"New York",
                      "LocationState":"New York",
                      "LocationZip":"10032",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Rochester",
                      "LocationState":"New York",
                      "LocationZip":"14621",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Rochester",
                      "LocationState":"New York",
                      "LocationZip":"14642",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Valhalla",
                      "LocationState":"New York",
                      "LocationZip":"10595",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Durham",
                      "LocationState":"North Carolina",
                      "LocationZip":"27710",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Cincinnati",
                      "LocationState":"Ohio",
                      "LocationZip":"45229",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Columbus",
                      "LocationState":"Ohio",
                      "LocationZip":"43210",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Yukon",
                      "LocationState":"Oklahoma",
                      "LocationZip":"73099",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Portland",
                      "LocationState":"Oregon",
                      "LocationZip":"97239",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Pittsburgh",
                      "LocationState":"Pennsylvania",
                      "LocationZip":"15232",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Warwick",
                      "LocationState":"Rhode Island",
                      "LocationZip":"02886",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Charleston",
                      "LocationState":"South Carolina",
                      "LocationZip":"29425",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"North Charleston",
                      "LocationState":"South Carolina",
                      "LocationZip":"29406",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Spartanburg",
                      "LocationState":"South Carolina",
                      "LocationZip":"29303",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Knoxville",
                      "LocationState":"Tennessee",
                      "LocationZip":"37920",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Nashville",
                      "LocationState":"Tennessee",
                      "LocationZip":"37203",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Austin",
                      "LocationState":"Texas",
                      "LocationZip":"78745",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Dallas",
                      "LocationState":"Texas",
                      "LocationZip":"75208",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Fort Sam Houston",
                      "LocationState":"Texas",
                      "LocationZip":"78234",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Houston",
                      "LocationState":"Texas",
                      "LocationZip":"77030",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"McAllen",
                      "LocationState":"Texas",
                      "LocationZip":"78504",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"San Antonio",
                      "LocationState":"Texas",
                      "LocationZip":"78236",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Spring",
                      "LocationState":"Texas",
                      "LocationZip":"77381",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"West Jordan",
                      "LocationState":"Utah",
                      "LocationZip":"84088",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Burlington",
                      "LocationState":"Vermont",
                      "LocationZip":"05401",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Fort Belvoir",
                      "LocationState":"Virginia",
                      "LocationZip":"22060",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Richmond",
                      "LocationState":"Virginia",
                      "LocationZip":"23226",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Seattle",
                      "LocationState":"Washington",
                      "LocationZip":"98109",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"South Charleston",
                      "LocationState":"West Virginia",
                      "LocationZip":"25309",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Madison",
                      "LocationState":"Wisconsin",
                      "LocationZip":"53792-5666",
                      "LocationCountry":"United States"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Quillota",
                      "LocationZip":"2260000",
                      "LocationCountry":"Chile"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Santiago",
                      "LocationZip":"7500539",
                      "LocationCountry":"Chile"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Santiago",
                      "LocationZip":"8380453",
                      "LocationCountry":"Chile"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Callao",
                      "LocationZip":"0",
                      "LocationCountry":"Peru"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Cercado De Lima",
                      "LocationZip":"LIMA 1",
                      "LocationCountry":"Peru"
                    },{
                      "LocationFacility":"Research Site",
                      "LocationCity":"Lima",
                      "LocationZip":"15036",
                      "LocationCountry":"Peru"
                    }
                  ]
                }
              },
              "ReferencesModule":{
                "ReferenceList":{
                  "Reference":[
                    {
                      "ReferenceType":"background",
                      "ReferenceCitation":"CDC. (Centers for Disease Control and Prevention). Coronavirus Disease 2019 (COVID-19), Symptoms of Coronavrus. https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/ symptoms.html. Published 2020. Accessed 01 July 2020."
                    },{
                      "ReferenceType":"background",
                      "ReferenceCitation":"FDA. (Food and Drug Administration). Guidance for Industry. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. . https://www.fda.gov/media/73679/download. Published 2007. Accessed 20 June 2020."
                    },{
                      "ReferencePMID":"32325038",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C, Halwe S, Jeong Y, Park YS, Kim JO, Song M, Boyd A, Tran N, Silman D, Poulton I, Datoo M, Marshall J, Themistocleous Y, Lawrie A, Roberts R, Berrie E, Becker S, Lambe T, Hill A, Ewer K, Gilbert S. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis. 2020 Jul;20(7):816-826. doi: 10.1016/S1473-3099(20)30160-2. Epub 2020 Apr 21. Erratum In: Lancet Infect Dis. 2020 May 12;: Lancet Infect Dis. 2020 Jun 8;:"
                    },{
                      "ReferencePMID":"27578435",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016 Sep 29;3(1):237-261. doi: 10.1146/annurev-virology-110615-042301. Epub 2016 Aug 25."
                    },{
                      "ReferencePMID":"32007145",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30."
                    },{
                      "ReferenceType":"background",
                      "ReferenceCitation":"SPEAC. (Safety Platform for Emergency Vaccines) D2.3 Priority list of adverse events of special interest: COVID-19. Work Package: WP2 Standards and Tools. v1.1. 05 March 2020. https://media.tghn.org/articles/COVID-19_AESIs_SPEAC_V1.1_5Mar2020.pdf. Published 2020. Accessed 14 June 2020."
                    },{
                      "ReferencePMID":"32731258",
                      "ReferenceType":"background",
                      "ReferenceCitation":"van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Perez-Perez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020 Oct;586(7830):578-582. doi: 10.1038/s41586-020-2608-y. Epub 2020 Jul 30. Erratum In: Nature. 2021 Feb;590(7844):E24."
                    },{
                      "ReferencePMID":"27371814",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Waldrop G, Doherty M, Vitoria M, Ford N. Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Trop Med Int Health. 2016 Sep;21(9):1124-30. doi: 10.1111/tmi.12746. Epub 2016 Jul 22."
                    },{
                      "ReferenceType":"background",
                      "ReferenceCitation":"WHO. (World Health Organization) Coronavirus disease (COVID-19) situation report-175. 13 July 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200713- covid-19-sitrep-175.pdf?sfvrsn=d6acef25_2. Published 2020. Accessed 13 July 2020."
                    },{
                      "ReferencePMID":"32015507",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3. Erratum In: Nature. 2020 Dec;588(7836):E6."
                    },{
                      "ReferenceType":"background",
                      "ReferenceCitation":"Clinical Study Protocol - 1.0 AstraZeneca AZD1222 - D8110C00001 CONFIDENTIAL AND PROPRIETARY 92 of 92"
                    },{
                      "ReferencePMID":"15033648",
                      "ReferenceType":"background",
                      "ReferenceCitation":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004 Apr 1;159(7):702-6. doi: 10.1093/aje/kwh090."
                    },{
                      "ReferencePMID":"36106642",
                      "ReferenceType":"derived",
                      "ReferenceCitation":"Sobieszczyk ME, Maaske J, Falsey AR, Sproule S, Robb ML, Frenck RW Jr, Tieu HV, Mayer KH, Corey L, Neuzil KM, Tong T, Brewinski Isaacs M, Janes H, Bansal H, Edwards LM, Green JA, Kelly EJ, Shoemaker K, Takas T, White T, Bhuyan P, Villafana T, Hirsch AI; AstraZeneca AZD1222 Clinical Study Group. Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months. J Clin Invest. 2022 Sep 15;132(18):e160565. doi: 10.1172/JCI160565."
                    },{
                      "ReferencePMID":"34587382",
                      "ReferenceType":"derived",
                      "ReferenceCitation":"Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A; AstraZeneca AZD1222 Clinical Study Group. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29."
                    }
                  ]
                },
                "SeeAlsoLinkList":{
                  "SeeAlsoLink":[
                    {
                      "SeeAlsoLinkLabel":"Statistical Analysis Plan (SAP)",
                      "SeeAlsoLinkURL":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D8110C00001&amp;attachmentIdentifier=58e8ea47-f2dc-4d66-bdba-535e1b50a3a3&amp;fileName=D8110C00001_SAP_Redacted.pdf&amp;versionIdentifier="
                    },{
                      "SeeAlsoLinkLabel":"D8110C00001-CSP-amendment-6_Redacted.pdf",
                      "SeeAlsoLinkURL":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D8110C00001&amp;attachmentIdentifier=90924b91-95c6-4d19-94f1-d5e77e059c8d&amp;fileName=D8110C00001_CSP_Amendment_6_Redacted.pdf&amp;versionIdentifier="
                    },{
                      "SeeAlsoLinkLabel":"CSR Synopsis",
                      "SeeAlsoLinkURL":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D8110C00001&amp;attachmentIdentifier=a07258a5-fe26-409c-a940-ae25552c538b&amp;fileName=D8110C00001_Clinical_Study_Report_Synopsis_Redacted.pdf&amp;versionIdentifier="
                    }
                  ]
                }
              },
              "IPDSharingStatementModule":{
                "IPDSharing":"Yes",
                "IPDSharingDescription":"Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure",
                "IPDSharingInfoTypeList":{
                  "IPDSharingInfoType":[
                    "Study Protocol",
                    "Statistical Analysis Plan (SAP)"
                  ]
                },
                "IPDSharingTimeFrame":"AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure",
                "IPDSharingAccessCriteria":"When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure",
                "IPDSharingURL":"https://astrazenecagroup-dt.pharmacm.com/DT/Home"
              }
            },
            "ResultsSection":{
              "ParticipantFlowModule":{
                "FlowPreAssignmentDetails":"The study had a screening period (14 days), followed by a treatment and follow-up period (up to 760 days). A total of 32451 participants were randomized in a 2:1 ratio to receive AZD1222 or placebo. The first participants randomized in each age group in the United States of America participated in a substudy to assess immunogenicity and reactogenicity.",
                "FlowRecruitmentDetails":"A total of 88 centers across 3 countries in the United States of America, Chile and Peru randomized adult participants who were healthy or had medically stable chronic diseases and were at increased risk for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) acquisition and coronavirus disease-2019 (COVID-19) in this study. First participant was randomized on 28 August 2020 and clinical data cut-off (DCO) date was 05 March 2021. Final analysis results will be reported at a later date.",
                "FlowGroupList":{
                  "FlowGroup":[
                    {
                      "FlowGroupId":"FG000",
                      "FlowGroupTitle":"AZD1222",
                      "FlowGroupDescription":"Participants were randomized to receive 2 intramuscular (IM) doses of either 5*10^10 viral particles (vp) (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                    },{
                      "FlowGroupId":"FG001",
                      "FlowGroupTitle":"Placebo",
                      "FlowGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                    }
                  ]
                },
                "FlowPeriodList":{
                  "FlowPeriod":[
                    {
                      "FlowPeriodTitle":"Overall Study",
                      "FlowMilestoneList":{
                        "FlowMilestone":[
                          {
                            "FlowMilestoneType":"STARTED",
                            "FlowMilestoneComment":"Participants randomized.",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"21635"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"10816"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"Participants Who Received First Dose",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"21583"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"10796"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"Participants Who Received Second Dose",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"20769"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"9951"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"COMPLETED",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"0"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"0"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"NOT COMPLETED",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"21635"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"10816"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "FlowDropWithdrawList":{
                        "FlowDropWithdraw":[
                          {
                            "FlowDropWithdrawType":"Ongoing in the study at clinical DCO for the primary analysis.",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"21090"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"10305"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Withdrawal by Subject",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"362"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"408"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Lost to Follow-up",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"157"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"86"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Protocol deviation",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"18"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"7"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Death",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"8"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"7"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Physician Decision",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"0"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"2"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Other",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"0"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "BaselineCharacteristicsModule":{
                "BaselinePopulationDescription":"The fully vaccinated analysis set (FVS) included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR)-positive confirmed COVID-19 infection.",
                "BaselineGroupList":{
                  "BaselineGroup":[
                    {
                      "BaselineGroupId":"BG000",
                      "BaselineGroupTitle":"AZD1222",
                      "BaselineGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                    },{
                      "BaselineGroupId":"BG001",
                      "BaselineGroupTitle":"Placebo",
                      "BaselineGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                    },{
                      "BaselineGroupId":"BG002",
                      "BaselineGroupTitle":"Total",
                      "BaselineGroupDescription":"Total of all reporting groups"
                    }
                  ]
                },
                "BaselineDenomList":{
                  "BaselineDenom":[
                    {
                      "BaselineDenomUnits":"Participants",
                      "BaselineDenomCountList":{
                        "BaselineDenomCount":[
                          {
                            "BaselineDenomCountGroupId":"BG000",
                            "BaselineDenomCountValue":"17662"
                          },{
                            "BaselineDenomCountGroupId":"BG001",
                            "BaselineDenomCountValue":"8550"
                          },{
                            "BaselineDenomCountGroupId":"BG002",
                            "BaselineDenomCountValue":"26212"
                          }
                        ]
                      }
                    }
                  ]
                },
                "BaselineMeasureList":{
                  "BaselineMeasure":[
                    {
                      "BaselineMeasureTitle":"Age, Continuous",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"years",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"49.8",
                                        "BaselineMeasurementSpread":"15.73"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"49.9",
                                        "BaselineMeasurementSpread":"15.71"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"49.9",
                                        "BaselineMeasurementSpread":"15.73"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Sex: Female, Male",
                      "BaselineMeasureParamType":"Count of Participants",
                      "BaselineMeasureUnitOfMeasure":"Participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineCategoryTitle":"Female",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"7740"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"3721"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"11461"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Male",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"9922"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"4829"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"14751"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Race/Ethnicity, Customized",
                      "BaselineMeasureParamType":"Count of Participants",
                      "BaselineMeasureUnitOfMeasure":"Participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineCategoryTitle":"Hispanic or Latino",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"4035"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"2064"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"6099"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Not Hispanic or Latino",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"13351"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"6370"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"19721"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Not reported",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"238"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"106"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"344"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Unknown",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"38"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"10"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"48"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Race/Ethnicity, Customized",
                      "BaselineMeasureParamType":"Count of Participants",
                      "BaselineMeasureUnitOfMeasure":"Participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineCategoryTitle":"Multiple",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"421"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"202"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"623"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"White",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"14011"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"6755"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"20766"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Black or African American",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"1401"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"706"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"2107"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Asian",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"747"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"352"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"1099"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"American Indian or Alaska Native",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"744"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"373"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"1117"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Native Hawaiian or Other Pacific Islander",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"50"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"14"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"64"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Not reported",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"207"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"110"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"317"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Unknown",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"81"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"38"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"119"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "OutcomeMeasuresModule":{
                "OutcomeMeasureList":{
                  "OutcomeMeasure":[
                    {
                      "OutcomeMeasureType":"Primary",
                      "OutcomeMeasureTitle":"Number of Participants Achieving Binary Response",
                      "OutcomeMeasureDescription":"A binary response, whereby a participant with negative serostatus at baseline is defined as a COVID-19 case if their first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurs ≥ 15 days post second dose of study intervention. Otherwise, a participant is not defined as a COVID-19 case. The primary efficacy analysis was performed once approximately 150 events meeting the primary efficacy outcome measure definition had occurred across the AZD1222 and placebo groups.",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"73"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"130"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% confidence interval (CI) and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"73.98",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"65.34",
                            "OutcomeAnalysisCIUpperLimit":"80.47"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Primary",
                      "OutcomeMeasureTitle":"Number of Participants With Adverse Events (AEs) Occurring Post Each Dose of Study Intervention",
                      "OutcomeMeasureDescription":"An AE is the development of any untoward medical occurrence in a clinical study participant administered medicinal product and which does not necessarily have a causal relationship with this medicinal product. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.",
                      "OutcomeMeasurePopulationDescription":"The safety analysis set included all participants who received at least one dose of study intervention.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to 28 days post second dose of study intervention, approximately 57 days",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"21587"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"10792"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"After first dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21587"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"10792"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5736"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1926"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"After second dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"20773"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"9947"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5074"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1797"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"After any dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21587"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"10792"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"8771"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3201"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Primary",
                      "OutcomeMeasureTitle":"Number of Participants With Serious Adverse Events (SAE), Medically Attended Adverse Events (MAAE), and Adverse Event of Special Interest (AESI) Occurring Throughout the Study",
                      "OutcomeMeasureDescription":"An SAE is an AE occurring during any study phase that fulfils one or more of the following criteria: death; immediately life-threatening; in-participant hospitalization or prolongation of existing hospitalization; persistent or significant disability or incapacity; congenital abnormality or birth defect; an important medical event. AESIs were events of scientific and medical interest specific to the further understanding of the study intervention safety profile and required close monitoring and rapid communication by the investigators to the sponsor. MAAEs are defined as AEs leading to medically-attended visits that were not routine visits for physical examination or vaccination, such as an emergency room visit, or an otherwise unscheduled visit to or from medical personnel (medical doctor) for any reason.",
                      "OutcomeMeasurePopulationDescription":"The safety analysis set included all participants who received at least one dose of study intervention.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"21587"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"10792"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"SAEs",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"140"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"78"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"MAAEs",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1617"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"815"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"AESIs",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"525"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"416"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Primary",
                      "OutcomeMeasureTitle":"Number of Participants With Local and Systemic Solicited AEs in the Substudy Only",
                      "OutcomeMeasureDescription":"Solicited AEs are local or systemic predefined events for assessment of reactogenicity. Solicited AEs were collected in a e-Diary only for participants in the substudy.",
                      "OutcomeMeasurePopulationDescription":"The safety analysis set included all participants who received at least one dose of study intervention. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to 7 days post each dose of study intervention, approximately 14 days",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Solicited local AEs: After first dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1830"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"920"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1250"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"173"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Solicited local AEs: After second dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1829"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"908"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"977"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"120"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Solicited local AEs: After any dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1944"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"979"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1440"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"239"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Solicited systemic AEs: After first dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1842"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"924"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1191"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"415"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Solicited systemic AEs: After second dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1821"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"905"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"862"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"314"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Solicited systemic AEs: After any dose",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1947"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"980"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1395"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"519"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With First Post-intervention Response for SARS-CoV-2 Nucleocapsid Antibodies Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of the first post-intervention response (negative at baseline to positive post intervention with study intervention) for SARS-CoV-2 nucleocapsid antibodies occurring ≥ 15 days post second dose of study intervention (key secondary endpoint).",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"156"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"202"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"64.32",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"56.05",
                            "OutcomeAnalysisCIUpperLimit":"71.03"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With First COVID-19 Symptomatic Illness Using Centers for Disease Control and Prevention (CDC) Criteria Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention using CDC criteria. Participant must present with at least one of the following symptoms per CDC criteria: fever, shortness of breath, difficulty breathing, chills, cough, fatigue, muscle aches, body aches, headache, new loss of taste, new loss of smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"95"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"145"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"69.65",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"60.68",
                            "OutcomeAnalysisCIUpperLimit":"76.57"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With First COVID-19 Symptomatic Illness Using University of Oxford-Defined Symptom Criteria Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention using University of Oxford-defined symptom criteria: new onset of fever (> 100 °Fahrenheit [> 37.8 °Celsius]), cough, shortness of breath, or anosmia/ageusia.",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"86"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"136"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"70.70",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"61.62",
                            "OutcomeAnalysisCIUpperLimit":"77.64"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With First Symptomatic COVID-19 Regardless of Evidence of Prior SARS-CoV-2 Infection Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of the first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring ≥ 15 days post second dose of study intervention regardless of evidence of prior SARS-CoV-2 infection (key secondary endpoint).",
                      "OutcomeMeasurePopulationDescription":"The FVS regardless of prior SARS-COV-2 infection included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"18563"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"9031"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"76"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"135"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"73.68",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"65.13",
                            "OutcomeAnalysisCIUpperLimit":"80.13"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With COVID-19 Severe or Critical Symptomatic Illness Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of SARS-CoV-2 RT-PCR-positive severe or critical symptomatic illness occurring ≥ 15 days post second dose of study intervention. The severity of COVID-19 was evaluated in participants with symptoms of COVID-19. Following are the findings regarding severe of critical symptomatic COVID-19: clinical signs at rest indicative of severe systemic illness; respiratory failure; evidence of shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; and death (key secondary endpoint).",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The exact 1-sided 97.5% CI and p-value were estimated based on stratified Poisson regression with exact conditional method (including study arm and stratification factor [age group at informed consent] as strata factor and log of total number of participants for each combination of study arm and strata as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression exact conditional",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"100.00",
                            "OutcomeAnalysisCIPctValue":"97.5",
                            "OutcomeAnalysisCINumSides":"1-Sided",
                            "OutcomeAnalysisCILowerLimit":"71.62"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With COVID-19 Severe or Critical Symptomatic Illness Occurring Post First Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of SARS-CoV-2 RT-PCR-positive severe or critical symptomatic illness occurring post first dose of study intervention. The severity of COVID-19 was evaluated in participants with symptoms of COVID-19. Following are the findings regarding severe of critical symptomatic COVID-19: clinical signs at rest indicative of severe systemic illness; respiratory failure; evidence of shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; and death.",
                      "OutcomeMeasurePopulationDescription":"The full analysis set (FAS) included all randomized participants who received at least one dose of study intervention, irrespective of their protocol adherence and continued participation in the study. Only participants who are seronegative at baseline were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"20589"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"10300"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"16"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI were estimated based on Poisson regression with robust variance (including study arm and age group at screening (18-65 years, ≥ 65 years) as covariates and log of the follow-up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"<0.001",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"84.97",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"58.97",
                            "OutcomeAnalysisCIUpperLimit":"94.50"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With COVID-19-Related Emergency Department Visits Occurring Post Second Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of COVID-19-related emergency department visits occurring ≥ 15 days post second dose of study intervention (key secondary endpoint).",
                      "OutcomeMeasurePopulationDescription":"The FVS included all participants in the full analysis set who were seronegative at baseline, received 2 doses of study intervention, and who remained on-study 15 days after their second dose without having had a prior SARS-CoV-2 RT-PCR-positive confirmed COVID-19 infection.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From 15 days post second dose up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of 17 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"17662"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"8550"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI and p-value were estimated based on Poisson regression with robust variance (including study arm and stratification factor [age group at informed consent] as covariates, and log of the follow up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisPValue":"0.005",
                            "OutcomeAnalysisStatisticalMethod":"Poisson regression with robust variance",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"94.80",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"58.98",
                            "OutcomeAnalysisCIUpperLimit":"99.34"
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Geometric Mean Titers (GMTs) for SARS-CoV-2 Spike (S) and Receptor Binding Domain (RBD) Antibodies as Measured by Meso Scale Discovery (MSD) Serology Assay",
                      "OutcomeMeasureDescription":"The GMT was calculated as the antilogarithm of Σ(log base 2 transformed titer/n), i.e. as the anti-logarithm transformation of the mean of the log-transformed titer, where 'n' is the number of participants with titer information.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Geometric Mean",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"arbitrary units per milliliter (AU/mL)",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"S Antibody Titer: Baseline (Day 1)",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1985"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"997"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"53.60",
                                        "OutcomeMeasurementLowerLimit":"50.74",
                                        "OutcomeMeasurementUpperLimit":"56.63"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"54.64",
                                        "OutcomeMeasurementLowerLimit":"50.04",
                                        "OutcomeMeasurementUpperLimit":"59.67"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1887"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"946"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1824.54",
                                        "OutcomeMeasurementLowerLimit":"1699.91",
                                        "OutcomeMeasurementUpperLimit":"1958.29"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"53.52",
                                        "OutcomeMeasurementLowerLimit":"48.91",
                                        "OutcomeMeasurementUpperLimit":"58.56"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1393"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"683"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5736.56",
                                        "OutcomeMeasurementLowerLimit":"5343.98",
                                        "OutcomeMeasurementUpperLimit":"6157.98"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"54.59",
                                        "OutcomeMeasurementLowerLimit":"48.61",
                                        "OutcomeMeasurementUpperLimit":"61.32"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1785"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"881"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"24224.11",
                                        "OutcomeMeasurementLowerLimit":"23044.03",
                                        "OutcomeMeasurementUpperLimit":"25464.63"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"58.64",
                                        "OutcomeMeasurementLowerLimit":"53.05",
                                        "OutcomeMeasurementUpperLimit":"64.81"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1611"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"772"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"19237.18",
                                        "OutcomeMeasurementLowerLimit":"18211.82",
                                        "OutcomeMeasurementUpperLimit":"20320.27"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"60.59",
                                        "OutcomeMeasurementLowerLimit":"53.93",
                                        "OutcomeMeasurementUpperLimit":"68.09"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Baseline (Day 1)",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1985"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"997"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"134.35",
                                        "OutcomeMeasurementLowerLimit":"129.69",
                                        "OutcomeMeasurementUpperLimit":"139.19"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"139.00",
                                        "OutcomeMeasurementLowerLimit":"131.01",
                                        "OutcomeMeasurementUpperLimit":"147.48"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1885"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"946"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"967.86",
                                        "OutcomeMeasurementLowerLimit":"899.17",
                                        "OutcomeMeasurementUpperLimit":"1041.79"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"138.69",
                                        "OutcomeMeasurementLowerLimit":"130.62",
                                        "OutcomeMeasurementUpperLimit":"147.26"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1389"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"684"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5132.51",
                                        "OutcomeMeasurementLowerLimit":"4751.09",
                                        "OutcomeMeasurementUpperLimit":"5544.54"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"145.08",
                                        "OutcomeMeasurementLowerLimit":"133.88",
                                        "OutcomeMeasurementUpperLimit":"157.22"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1783"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"881"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"29487.39",
                                        "OutcomeMeasurementLowerLimit":"27987.19",
                                        "OutcomeMeasurementUpperLimit":"31068.00"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"146.06",
                                        "OutcomeMeasurementLowerLimit":"136.18",
                                        "OutcomeMeasurementUpperLimit":"156.66"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1608"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"771"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"23360.08",
                                        "OutcomeMeasurementLowerLimit":"22083.19",
                                        "OutcomeMeasurementUpperLimit":"24710.81"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"155.15",
                                        "OutcomeMeasurementLowerLimit":"142.67",
                                        "OutcomeMeasurementUpperLimit":"168.73"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Geometric Mean Fold Rise (GMFR) for SARS-CoV-2 S and RBD Antibodies as Measured by MSD Serology Assay",
                      "OutcomeMeasureDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. GMFR was calculated as anti-logarithm of Σ (log base 2 transformed (post-vaccination titer/ pre-vaccination titer)/n). Where 'n' is the number of participants with titer information.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Geometric Mean",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"ratio",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"S Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1856"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"935"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"34.04",
                                        "OutcomeMeasurementLowerLimit":"31.63",
                                        "OutcomeMeasurementUpperLimit":"36.63"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.97",
                                        "OutcomeMeasurementLowerLimit":"0.94",
                                        "OutcomeMeasurementUpperLimit":"1.00"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1369"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"675"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"107.83",
                                        "OutcomeMeasurementLowerLimit":"99.38",
                                        "OutcomeMeasurementUpperLimit":"117.01"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.92",
                                        "OutcomeMeasurementLowerLimit":"0.87",
                                        "OutcomeMeasurementUpperLimit":"0.98"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1748"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"869"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"453.33",
                                        "OutcomeMeasurementLowerLimit":"423.38",
                                        "OutcomeMeasurementUpperLimit":"485.40"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.08",
                                        "OutcomeMeasurementLowerLimit":"1.02",
                                        "OutcomeMeasurementUpperLimit":"1.14"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1587"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"760"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"364.28",
                                        "OutcomeMeasurementLowerLimit":"338.30",
                                        "OutcomeMeasurementUpperLimit":"392.25"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.14",
                                        "OutcomeMeasurementLowerLimit":"1.04",
                                        "OutcomeMeasurementUpperLimit":"1.24"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1854"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"935"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"7.20",
                                        "OutcomeMeasurementLowerLimit":"6.72",
                                        "OutcomeMeasurementUpperLimit":"7.72"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.99",
                                        "OutcomeMeasurementLowerLimit":"0.98",
                                        "OutcomeMeasurementUpperLimit":"1.01"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1365"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"676"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"38.83",
                                        "OutcomeMeasurementLowerLimit":"35.89",
                                        "OutcomeMeasurementUpperLimit":"42.01"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.01",
                                        "OutcomeMeasurementLowerLimit":"0.98",
                                        "OutcomeMeasurementUpperLimit":"1.05"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1747"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"869"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"220.84",
                                        "OutcomeMeasurementLowerLimit":"207.94",
                                        "OutcomeMeasurementUpperLimit":"234.53"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.05",
                                        "OutcomeMeasurementLowerLimit":"1.01",
                                        "OutcomeMeasurementUpperLimit":"1.09"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1584"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"759"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"174.81",
                                        "OutcomeMeasurementLowerLimit":"163.74",
                                        "OutcomeMeasurementUpperLimit":"186.64"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.12",
                                        "OutcomeMeasurementLowerLimit":"1.06",
                                        "OutcomeMeasurementUpperLimit":"1.20"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Percentage of Participants With Seroresponse to the S and RBD Antigens of AZD1222 as Measured by MSD Serology Assay",
                      "OutcomeMeasureDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. The percentage of participants with a post-intervention seroresponse (≥ 4-fold rise in titers from baseline value to 28 days post each dose) to the S and RBD antigens of AZD1222 as measured by MSD serology assay is reported.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureUnitOfMeasure":"percentage of participants",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"S Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1856"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"935"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"89.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1369"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"675"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"97.1"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1748"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"869"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"99.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"S Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1587"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"760"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"99.1"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1854"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"935"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"61.3"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1365"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"676"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"92.2"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1747"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"869"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"98.8"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"RBD Antibody Titer: Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1584"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"759"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"98.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.3"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"GMTs for SARS-CoV-2 Neutralizing Antibodies as Measured by Pseudo-neutralization Assay",
                      "OutcomeMeasureDescription":"The GMT was calculated as the antilogarithm of Σ(log base 2 transformed titer/n), i.e. as the anti-logarithm transformation of the mean of the log-transformed titer, where 'n' is the number of participants with titer information.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Geometric Mean",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"AU/mL",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Baseline (Day 1)",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1926"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"967"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"20.59",
                                        "OutcomeMeasurementLowerLimit":"20.31",
                                        "OutcomeMeasurementUpperLimit":"20.88"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"21.43",
                                        "OutcomeMeasurementLowerLimit":"20.79",
                                        "OutcomeMeasurementUpperLimit":"22.09"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1627"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"851"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"41.37",
                                        "OutcomeMeasurementLowerLimit":"38.96",
                                        "OutcomeMeasurementUpperLimit":"43.93"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"21.48",
                                        "OutcomeMeasurementLowerLimit":"20.79",
                                        "OutcomeMeasurementUpperLimit":"22.20"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1047"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"573"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"65.16",
                                        "OutcomeMeasurementLowerLimit":"59.72",
                                        "OutcomeMeasurementUpperLimit":"71.09"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"23.59",
                                        "OutcomeMeasurementLowerLimit":"22.15",
                                        "OutcomeMeasurementUpperLimit":"25.13"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1196"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"644"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"228.19",
                                        "OutcomeMeasurementLowerLimit":"212.92",
                                        "OutcomeMeasurementUpperLimit":"244.57"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"22.44",
                                        "OutcomeMeasurementLowerLimit":"21.42",
                                        "OutcomeMeasurementUpperLimit":"23.51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"743"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"400"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"245.56",
                                        "OutcomeMeasurementLowerLimit":"223.66",
                                        "OutcomeMeasurementUpperLimit":"269.61"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"22.79",
                                        "OutcomeMeasurementLowerLimit":"21.39",
                                        "OutcomeMeasurementUpperLimit":"24.28"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"GMFR for SARS-CoV-2 Neutralizing Antibodies as Measured by Pseudo-neutralization Assay",
                      "OutcomeMeasureDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. GMFR was calculated as anti-logarithm of Σ (log base 2 transformed (post-vaccination titer/ pre-vaccination titer)/n). Where 'n' is the number of participants with titer information.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Geometric Mean",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"ratio",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1573"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"825"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"2.03",
                                        "OutcomeMeasurementLowerLimit":"1.91",
                                        "OutcomeMeasurementUpperLimit":"2.15"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.99",
                                        "OutcomeMeasurementLowerLimit":"0.98",
                                        "OutcomeMeasurementUpperLimit":"1.01"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1021"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"561"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"3.20",
                                        "OutcomeMeasurementLowerLimit":"2.94",
                                        "OutcomeMeasurementUpperLimit":"3.49"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.07",
                                        "OutcomeMeasurementLowerLimit":"1.02",
                                        "OutcomeMeasurementUpperLimit":"1.13"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1150"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"620"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"11.22",
                                        "OutcomeMeasurementLowerLimit":"10.48",
                                        "OutcomeMeasurementUpperLimit":"12.02"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.05",
                                        "OutcomeMeasurementLowerLimit":"1.00",
                                        "OutcomeMeasurementUpperLimit":"1.09"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"720"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"386"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"12.04",
                                        "OutcomeMeasurementLowerLimit":"10.98",
                                        "OutcomeMeasurementUpperLimit":"13.20"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.04",
                                        "OutcomeMeasurementLowerLimit":"0.99",
                                        "OutcomeMeasurementUpperLimit":"1.10"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Percentage of Participants With Seroresponse to SARS-CoV-2 Neutralizing Antibodies of AZD1222 as Measured by Pseudo-neutralization Assay",
                      "OutcomeMeasureDescription":"The fold rise was calculated as the ratio of the post-vaccination titer level to the pre-vaccination titer level. The percentage of participants with a post-intervention seroresponse (≥ 4-fold rise in titers from baseline value to 28 days post each dose) to SARS-CoV-2 neutralizing antibodies of AZD1222 as measured by pseudo-neutralization assay is reported.",
                      "OutcomeMeasurePopulationDescription":"The immunogenicity analysis population included all participants in the safety analysis set who had no protocol deviations judged to have the potential to interfere with the generation or interpretation of an immune response. Only participants included in the substudy were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureUnitOfMeasure":"percentage of participants",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and Days 15, 29, 43, and 57",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"2037"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"1013"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Day 15",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1573"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"825"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"24.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 29",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1021"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"561"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"40.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 43",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"1150"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"620"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"84.9"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Day 57",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"720"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"386"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"84.0"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.6"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Number of Participants With COVID-19 Symptomatic Illness Occurring Post First Dose of Study Intervention",
                      "OutcomeMeasureDescription":"The incidence of SARS-CoV-2 RT-PCR-positive symptomatic illness occurring post first dose of study intervention.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all randomized participants who received at least one dose of study intervention, irrespective of their protocol adherence and continued participation in the study. Only participants who are seronegative at baseline were analyzed.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Count of Participants",
                      "OutcomeMeasureUnitOfMeasure":"Participants",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to DCO of 05 March 2021 or study discontinuation or unblinding or receipt of non-study COVID-19 vaccination, up to a maximum of approximately 27 weeks",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"AZD1222",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Placebo",
                            "OutcomeGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"20589"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"10300"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"287"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"303"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeAnalysisList":{
                        "OutcomeAnalysis":[
                          {
                            "OutcomeAnalysisGroupIdList":{
                              "OutcomeAnalysisGroupId":[
                                "OG000",
                                "OG001"
                              ]
                            },
                            "OutcomeAnalysisGroupDescription":"The 95% CI were estimated based on Poisson regression with robust variance (including study arm and age group at screening (18-65 years, ≥ 65 years) as covariates and log of the follow-up time as an offset).",
                            "OutcomeAnalysisNonInferiorityType":"Superiority",
                            "OutcomeAnalysisParamType":"Vaccine efficacy",
                            "OutcomeAnalysisParamValue":"54.47",
                            "OutcomeAnalysisCIPctValue":"95",
                            "OutcomeAnalysisCINumSides":"2-Sided",
                            "OutcomeAnalysisCILowerLimit":"46.48",
                            "OutcomeAnalysisCIUpperLimit":"61.26"
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "AdverseEventsModule":{
                "EventsFrequencyThreshold":"1",
                "EventsTimeFrame":"AEs are reported from first administration of study intervention up to clinical DCO of 05 March 2021, up to a maximum of approximately 27 weeks.",
                "EventsDescription":"The safety analysis set included all participants who received at least one dose of study intervention. Adverse events data reported for double-blind period only. All-cause mortality data reported for overall period (double-blind period and unblinded period).",
                "EventGroupList":{
                  "EventGroup":[
                    {
                      "EventGroupId":"EG000",
                      "EventGroupTitle":"AZD1222",
                      "EventGroupDescription":"Participants were randomized to receive 2 IM doses of either 5*10^10 vp (nominal, ± 1.5*10^10 vp) AZD1222 on Days 1 and 29.",
                      "EventGroupDeathsNumAffected":"8",
                      "EventGroupDeathsNumAtRisk":"21587",
                      "EventGroupSeriousNumAffected":"140",
                      "EventGroupSeriousNumAtRisk":"21587",
                      "EventGroupOtherNumAffected":"6835",
                      "EventGroupOtherNumAtRisk":"21587"
                    },{
                      "EventGroupId":"EG001",
                      "EventGroupTitle":"Placebo",
                      "EventGroupDescription":"Participants were randomized to receive 2 IM doses of placebo matching with AZD1222 on Days 1 and 29.",
                      "EventGroupDeathsNumAffected":"7",
                      "EventGroupDeathsNumAtRisk":"10792",
                      "EventGroupSeriousNumAffected":"78",
                      "EventGroupSeriousNumAtRisk":"10792",
                      "EventGroupOtherNumAffected":"2206",
                      "EventGroupOtherNumAtRisk":"10792"
                    }
                  ]
                },
                "SeriousEventList":{
                  "SeriousEvent":[
                    {
                      "SeriousEventTerm":"Haemoptysis",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Haemothorax",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pneumothorax",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pulmonary embolism",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Respiratory failure",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Optic ischaemic neuropathy",
                      "SeriousEventOrganSystem":"Eye disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Petechiae",
                      "SeriousEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Retinal detachment",
                      "SeriousEventOrganSystem":"Eye disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Aortic aneurysm rupture",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Arterial haemorrhage",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Deep vein thrombosis",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypertensive emergency",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypotension",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Aphthous ulcer",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chronic gastritis",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Constipation",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Diarrhoea",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Diverticulum intestinal haemorrhagic",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Duodenal ulcer haemorrhage",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gastric ulcer haemorrhage",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Acute myocardial infarction",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gastrointestinal haemorrhage",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Angina pectoris",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ileus",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Incarcerated inguinal hernia",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Internal hernia",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Arrhythmia",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intestinal obstruction",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Obstructive pancreatitis",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Atrial fibrillation",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"4",
                            "SeriousEventStatsNumAffected":"4",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Oesophagitis",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pancreatitis",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Atrioventricular block",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Small intestinal obstruction",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Atrioventricular block second degree",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Bradycardia",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Death",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Bundle branch block right",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypothermia",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cardiac arrest",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cardiac failure congestive",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Anaemia",
                      "SeriousEventOrganSystem":"Blood and lymphatic system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Oedema peripheral",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Bile duct stone",
                      "SeriousEventOrganSystem":"Hepatobiliary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cholecystitis",
                      "SeriousEventOrganSystem":"Hepatobiliary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cholecystitis acute",
                      "SeriousEventOrganSystem":"Hepatobiliary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chronic left ventricular failure",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ischaemic hepatitis",
                      "SeriousEventOrganSystem":"Hepatobiliary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Coronary artery disease",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Appendicitis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"7",
                            "SeriousEventStatsNumAffected":"7",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"COVID-19",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"5",
                            "SeriousEventStatsNumAffected":"5",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"COVID-19 pneumonia",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"10",
                            "SeriousEventStatsNumAffected":"10",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cellulitis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cholecystitis infective",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Myocardial infarction",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Device related infection",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Diverticulitis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Extradural abscess",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gastroenteritis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gastroenteritis viral",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Blood loss anaemia",
                      "SeriousEventOrganSystem":"Blood and lymphatic system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Supraventricular tachycardia",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Infected skin ulcer",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Peritonsillar abscess",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pneumonia",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"7",
                            "SeriousEventStatsNumAffected":"7",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pneumonia bacterial",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Psoas abscess",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pyelonephritis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pyelonephritis acute",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Haemorrhagic arteriovenous malformation",
                      "SeriousEventOrganSystem":"Congenital, familial and genetic disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Scrotal cellulitis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Sepsis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Septic shock",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Streptococcal bacteraemia",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Toxic shock syndrome staphylococcal",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Urinary tract infection",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Viral infection",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Accident",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ankle fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chemical peritonitis",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Fall",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Femoral neck fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Femur fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gun shot wound",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hip fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ilium fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intentional overdose",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Joint dislocation",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ligament sprain",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Median nerve injury",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Overdose",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pneumothorax traumatic",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Rib fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Road traffic accident",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Toxicity to various agents",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Traumatic intracranial haematoma",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Traumatic intracranial haemorrhage",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Traumatic liver injury",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Neurosensory hypoacusis",
                      "SeriousEventOrganSystem":"Ear and labyrinth disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Oxygen saturation decreased",
                      "SeriousEventOrganSystem":"Investigations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Precancerous cells present",
                      "SeriousEventOrganSystem":"Investigations",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Diabetic ketoacidosis",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Gout",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Vertigo positional",
                      "SeriousEventOrganSystem":"Ear and labyrinth disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypercalcaemia",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hyponatraemia",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypovolaemia",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Type 2 diabetes mellitus",
                      "SeriousEventOrganSystem":"Metabolism and nutrition disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intervertebral disc protrusion",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Lumbar spinal stenosis",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Muscle spasms",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Osteoarthritis",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Rhabdomyolysis",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Spinal stenosis",
                      "SeriousEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Borderline mucinous tumour of ovary",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Brain neoplasm",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Breast cancer",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Choroid melanoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Thyrotoxic crisis",
                      "SeriousEventOrganSystem":"Endocrine disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Huerthle cell carcinoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intraductal proliferative breast lesion",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Invasive ductal breast carcinoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Lung adenocarcinoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Lung neoplasm malignant",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Malignant neoplasm of pleura",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Metastatic squamous cell carcinoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Neuroendocrine tumour",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Papillary thyroid cancer",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Prostate cancer",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Prostate cancer stage III",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Transitional cell carcinoma",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Cerebral artery occlusion",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chronic inflammatory demyelinating polyradiculoneuropathy",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Haemorrhagic transformation stroke",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypoaesthesia",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intraventricular haemorrhage",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Ischaemic stroke",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"4",
                            "SeriousEventStatsNumAffected":"4",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Lumbar radiculopathy",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Metabolic encephalopathy",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Paraesthesia",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Peripheral sensory neuropathy",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Post stroke seizure",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Sensory loss",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Syncope",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Transient ischaemic attack",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Abortion spontaneous",
                      "SeriousEventOrganSystem":"Pregnancy, puerperium and perinatal conditions",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Anxiety",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Major depression",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Schizoaffective disorder",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Schizophrenia",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Suicidal ideation",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Suicide attempt",
                      "SeriousEventOrganSystem":"Psychiatric disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Acute kidney injury",
                      "SeriousEventOrganSystem":"Renal and urinary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Bladder outlet obstruction",
                      "SeriousEventOrganSystem":"Renal and urinary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Nephrolithiasis",
                      "SeriousEventOrganSystem":"Renal and urinary disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Adenomyosis",
                      "SeriousEventOrganSystem":"Reproductive system and breast disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Prostatitis",
                      "SeriousEventOrganSystem":"Reproductive system and breast disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Acute respiratory distress syndrome",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Acute respiratory failure",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Asphyxia",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chronic obstructive pulmonary disease",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 23.1",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"21587"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OtherEventList":{
                  "OtherEvent":[
                    {
                      "OtherEventTerm":"Nasal congestion",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"361",
                            "OtherEventStatsNumAffected":"351",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"231",
                            "OtherEventStatsNumAffected":"217",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Oropharyngeal pain",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"452",
                            "OtherEventStatsNumAffected":"436",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"250",
                            "OtherEventStatsNumAffected":"241",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Rhinorrhoea",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"515",
                            "OtherEventStatsNumAffected":"490",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"263",
                            "OtherEventStatsNumAffected":"253",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Diarrhoea",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"581",
                            "OtherEventStatsNumAffected":"549",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"250",
                            "OtherEventStatsNumAffected":"235",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Nausea",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"261",
                            "OtherEventStatsNumAffected":"255",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"101",
                            "OtherEventStatsNumAffected":"99",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Chills",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"447",
                            "OtherEventStatsNumAffected":"438",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"108",
                            "OtherEventStatsNumAffected":"105",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Fatigue",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1126",
                            "OtherEventStatsNumAffected":"1105",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"397",
                            "OtherEventStatsNumAffected":"388",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Injection site pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1491",
                            "OtherEventStatsNumAffected":"1474",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"222",
                            "OtherEventStatsNumAffected":"219",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1910",
                            "OtherEventStatsNumAffected":"1769",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"265",
                            "OtherEventStatsNumAffected":"249",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Reactogenicity event",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"318",
                            "OtherEventStatsNumAffected":"282",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"51",
                            "OtherEventStatsNumAffected":"45",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"COVID-19",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"373",
                            "OtherEventStatsNumAffected":"368",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"352",
                            "OtherEventStatsNumAffected":"352",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Injection related reaction",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"375",
                            "OtherEventStatsNumAffected":"328",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"73",
                            "OtherEventStatsNumAffected":"66",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Body temperature increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"772",
                            "OtherEventStatsNumAffected":"742",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"93",
                            "OtherEventStatsNumAffected":"92",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Arthralgia",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"268",
                            "OtherEventStatsNumAffected":"252",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"66",
                            "OtherEventStatsNumAffected":"62",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Myalgia",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"450",
                            "OtherEventStatsNumAffected":"444",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"125",
                            "OtherEventStatsNumAffected":"120",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pain in extremity",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"317",
                            "OtherEventStatsNumAffected":"303",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"77",
                            "OtherEventStatsNumAffected":"76",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Headache",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1427",
                            "OtherEventStatsNumAffected":"1359",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"534",
                            "OtherEventStatsNumAffected":"501",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cough",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 23.1",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"359",
                            "OtherEventStatsNumAffected":"345",
                            "OtherEventStatsNumAtRisk":"21587"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"196",
                            "OtherEventStatsNumAffected":"192",
                            "OtherEventStatsNumAtRisk":"10792"
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "MoreInfoModule":{
                "CertainAgreement":{
                  "AgreementPISponsorEmployee":"No",
                  "AgreementRestrictiveAgreement":"Yes"
                },
                "PointOfContact":{
                  "PointOfContactTitle":"Global Clinical Lead",
                  "PointOfContactOrganization":"AstraZeneca",
                  "PointOfContactEMail":"information.center@astrazeneca.com",
                  "PointOfContactPhone":"1-877-240-9479"
                }
              }
            },
            "DocumentSection":{
              "LargeDocumentModule":{
                "LargeDocList":{
                  "LargeDoc":[
                    {
                      "LargeDocTypeAbbrev":"Prot",
                      "LargeDocHasProtocol":"Yes",
                      "LargeDocHasSAP":"No",
                      "LargeDocHasICF":"No",
                      "LargeDocLabel":"Study Protocol",
                      "LargeDocDate":"February 19, 2021",
                      "LargeDocUploadDate":"03/03/2022 14:23",
                      "LargeDocFilename":"Prot_000.pdf"
                    },{
                      "LargeDocTypeAbbrev":"SAP",
                      "LargeDocHasProtocol":"No",
                      "LargeDocHasSAP":"Yes",
                      "LargeDocHasICF":"No",
                      "LargeDocLabel":"Statistical Analysis Plan",
                      "LargeDocDate":"February 28, 2021",
                      "LargeDocUploadDate":"03/03/2022 14:23",
                      "LargeDocFilename":"SAP_001.pdf"
                    }
                  ]
                }
              }
            },
            "DerivedSection":{
              "MiscInfoModule":{
                "VersionHolder":"August 17, 2023",
                "RemovedCountryList":{
                  "RemovedCountry":[
                    "Argentina",
                    "Colombia",
                    "France"
                  ]
                },
                "SubmissionTracking":{}
              },
              "ConditionBrowseModule":{
                "ConditionMeshList":{
                  "ConditionMesh":[
                    {
                      "ConditionMeshId":"D000086382",
                      "ConditionMeshTerm":"COVID-19"
                    }
                  ]
                },
                "ConditionAncestorList":{
                  "ConditionAncestor":[
                    {
                      "ConditionAncestorId":"D000011024",
                      "ConditionAncestorTerm":"Pneumonia, Viral"
                    },{
                      "ConditionAncestorId":"D000011014",
                      "ConditionAncestorTerm":"Pneumonia"
                    },{
                      "ConditionAncestorId":"D000012141",
                      "ConditionAncestorTerm":"Respiratory Tract Infections"
                    },{
                      "ConditionAncestorId":"D000007239",
                      "ConditionAncestorTerm":"Infections"
                    },{
                      "ConditionAncestorId":"D000014777",
                      "ConditionAncestorTerm":"Virus Diseases"
                    },{
                      "ConditionAncestorId":"D000018352",
                      "ConditionAncestorTerm":"Coronavirus Infections"
                    },{
                      "ConditionAncestorId":"D000003333",
                      "ConditionAncestorTerm":"Coronaviridae Infections"
                    },{
                      "ConditionAncestorId":"D000030341",
                      "ConditionAncestorTerm":"Nidovirales Infections"
                    },{
                      "ConditionAncestorId":"D000012327",
                      "ConditionAncestorTerm":"RNA Virus Infections"
                    },{
                      "ConditionAncestorId":"D000008171",
                      "ConditionAncestorTerm":"Lung Diseases"
                    },{
                      "ConditionAncestorId":"D000012140",
                      "ConditionAncestorTerm":"Respiratory Tract Diseases"
                    }
                  ]
                },
                "ConditionBrowseLeafList":{
                  "ConditionBrowseLeaf":[
                    {
                      "ConditionBrowseLeafId":"M2562",
                      "ConditionBrowseLeafName":"COVID-19",
                      "ConditionBrowseLeafAsFound":"COVID-19",
                      "ConditionBrowseLeafRelevance":"high"
                    },{
                      "ConditionBrowseLeafId":"M13594",
                      "ConditionBrowseLeafName":"Pneumonia",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M13604",
                      "ConditionBrowseLeafName":"Pneumonia, Viral",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M9973",
                      "ConditionBrowseLeafName":"Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M6058",
                      "ConditionBrowseLeafName":"Communicable Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M14668",
                      "ConditionBrowseLeafName":"Respiratory Tract Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M17212",
                      "ConditionBrowseLeafName":"Virus Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M20180",
                      "ConditionBrowseLeafName":"Coronavirus Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M6245",
                      "ConditionBrowseLeafName":"Coronaviridae Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M23375",
                      "ConditionBrowseLeafName":"Nidovirales Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M14839",
                      "ConditionBrowseLeafName":"RNA Virus Infections",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M10858",
                      "ConditionBrowseLeafName":"Lung Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M14667",
                      "ConditionBrowseLeafName":"Respiratory Tract Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    }
                  ]
                },
                "ConditionBrowseBranchList":{
                  "ConditionBrowseBranch":[
                    {
                      "ConditionBrowseBranchAbbrev":"BC01",
                      "ConditionBrowseBranchName":"Infections"
                    },{
                      "ConditionBrowseBranchAbbrev":"BC08",
                      "ConditionBrowseBranchName":"Respiratory Tract (Lung and Bronchial) Diseases"
                    },{
                      "ConditionBrowseBranchAbbrev":"All",
                      "ConditionBrowseBranchName":"All Conditions"
                    },{
                      "ConditionBrowseBranchAbbrev":"BC23",
                      "ConditionBrowseBranchName":"Symptoms and General Pathology"
                    }
                  ]
                }
              },
              "InterventionBrowseModule":{
                "InterventionBrowseLeafList":{
                  "InterventionBrowseLeaf":[
                    {
                      "InterventionBrowseLeafId":"M17050",
                      "InterventionBrowseLeafName":"Vaccines",
                      "InterventionBrowseLeafRelevance":"low"
                    },{
                      "InterventionBrowseLeafId":"M340754",
                      "InterventionBrowseLeafName":"polysaccharide-K",
                      "InterventionBrowseLeafRelevance":"low"
                    }
                  ]
                },
                "InterventionBrowseBranchList":{
                  "InterventionBrowseBranch":[
                    {
                      "InterventionBrowseBranchAbbrev":"All",
                      "InterventionBrowseBranchName":"All Drugs and Chemicals"
                    },{
                      "InterventionBrowseBranchAbbrev":"Infe",
                      "InterventionBrowseBranchName":"Anti-Infective Agents"
                    },{
                      "InterventionBrowseBranchAbbrev":"ANeo",
                      "InterventionBrowseBranchName":"Antineoplastic Agents"
                    }
                  ]
                }
              }
            }
          }
        }
      ]
    }
  }
  